Page last updated: 2024-09-03

marimastat and B16 Melanoma

marimastat has been researched along with B16 Melanoma in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baxter, AD; Bhogal, R; Bird, J; Keily, JF; Manallack, DT; Montana, JG; Owen, DA; Pitt, WR; Watson, RJ; Wills, RE	1
Bertrand, M; Casara, P; Chollet, AM; Guilbaud, N; Hennig, P; Le Diguarher, T; Pierré, A; Raimbaud, E; Sabatini, M; Tucker, GC	1

Other Studies

2 other study(ies) available for marimastat and B16 Melanoma

Article	Year
Arylsulphonyl hydroxamic acids: potent and selective matrix metalloproteinase inhibitors. Bioorganic & medicinal chemistry letters, 2001, Jun-04, Volume: 11, Issue:11 Topics: Animals; Antineoplastic Agents; Arthritis, Experimental; Disease Models, Animal; Enzyme Inhibitors; Hydroxamic Acids; Matrix Metalloproteinase Inhibitors; Melanoma, Experimental; Mice	2001
Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors. Journal of medicinal chemistry, 2003, Aug-28, Volume: 46, Issue:18 Topics: Administration, Oral; Animals; Antineoplastic Agents; Biological Availability; Caco-2 Cells; Cyclopentanes; Humans; In Vitro Techniques; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Melanoma, Experimental; Mice; Microsomes, Liver; Models, Molecular; Molecular Conformation; Neoplasm Metastasis; Permeability; Phthalimides; Protease Inhibitors; Stereoisomerism; Structure-Activity Relationship; Triazines	2003

Article

Year

Arylsulphonyl hydroxamic acids: potent and selective matrix metalloproteinase inhibitors.

Bioorganic & medicinal chemistry letters, 2001, Jun-04, Volume: 11, Issue:11

Topics: Animals; Antineoplastic Agents; Arthritis, Experimental; Disease Models, Animal; Enzyme Inhibitors; Hydroxamic Acids; Matrix Metalloproteinase Inhibitors; Melanoma, Experimental; Mice

2001

Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.

Journal of medicinal chemistry, 2003, Aug-28, Volume: 46, Issue:18

Topics: Administration, Oral; Animals; Antineoplastic Agents; Biological Availability; Caco-2 Cells; Cyclopentanes; Humans; In Vitro Techniques; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Melanoma, Experimental; Mice; Microsomes, Liver; Models, Molecular; Molecular Conformation; Neoplasm Metastasis; Permeability; Phthalimides; Protease Inhibitors; Stereoisomerism; Structure-Activity Relationship; Triazines

2003